Professional Documents
Culture Documents
Diabetes Mellitus Pharmacology Mindmap
Diabetes Mellitus Pharmacology Mindmap
ultra short-acting
(onset: 5-15min)
short-acting
(onset: 30-60min)
intermediate-acting
(onset: 1-2h)
tolazamide (Tolinase)
Insulins
Mechanism
Therapeutic Use
1st generation
Insulins
Adverse Eects
acetohexamide (Dymelor)
Drugs
Drugs
Alpha-Glucosidase Inhibitors
long-acting
(onset: 1.5-3h)
chlorpropamide (Diabinese)
Drugs
2nd generation
Amylin Analog
Sulfonylureas
glimepiride (Amaryl)
pramlintide
Mechanism
Therapeutic Use
Adverse Eects
Mechanism
INSULIN SECRETAGOGUES
Therapeutic Use
Drugs
Adverse Eects
Alpha-Glucosidase Inhibitors
Therapeutic Use
Adverse Eects
Drugs
repaglinide (Prandin)
miglitol (Glyset)
Mechanism
Other
nateglinide (Starlix)
acarbose (Precose)
Advantages
Meglitinides
(Non-Sulfonylureas)
-glinide
Mechanism
Therapeutic Use
Other
Drugs
Adverse Eects
metformin (Glucophage)
Mechanism
Drugs
Therapeutic Use
Mechanism
Therapeutic Use
Adverse Eects
Biguanide
Drugs
Adverse Eects
INCRETIN MIMETICS
Advantages
withdrawn from market after a number
of deaths due to hepatotoxicity
exenatide
Mechanism
Therapeutic Use
Adverse Eects
troglitazone
sitagliptin (Januvia)
INSULIN SENSITIZERS
Drugs
pioglitazone (Actos)
Mechanism
Incretin Eect
Incretin Hormones
Therapeutic Use
Adverse Eects
Other
Incretin Info
Thiazolidinediones
-glitazones
COMBINATION THERAPY